Stem-cell therapy

Global Stem Cell Therapies Therapy Market: for Focus on Cardiovascular & and Metabolic Disorders, 2019-2030

Retrieved on: 
Tuesday, August 27, 2019
Branches of biology, Biology, Life sciences, Biotechnology, Cell biology, Cloning, Developmental biology, Stem cell, Stem-cell therapy

Several stakeholders are engaged in efforts to advance the development of regenerative therapies for both cardiovascular and metabolic disorders.

Key Points: 
  • Several stakeholders are engaged in efforts to advance the development of regenerative therapies for both cardiovascular and metabolic disorders.
  • SCOPE OF THE REPORTThe "Global Stem Cell Therapies Therapy Market: for Focus on Cardiovascular & and Metabolic Disorders, 2019-2030" report features an extensive study of the current market landscape and the future potential of stem cell therapies in treating the aforementioned clinical conditions.
  • The study includes all stem cell therapies that are being developed for the treatment of cardiovascular and metabolic disorders.
  • Further, around 150 peer-reviewed articles related to stem cell therapies for cardiovascular and metabolic disorders were published between 2013 and 2018.

Tests Show AAGP® Preserved and Enabled Retinal Cells to Mature Without Compromise after 5-Month Milestone

Retrieved on: 
Friday, August 23, 2019
Research, Clinical trials, Stem cells, Biotechnology, Health, Optical, Science, Branches of biology, Biology, Life sciences, Stem cells, Emerging technologies, Retina, Visual system, Blindness, Regenerative biomedicine, Induced stem cells, Stem-cell therapy

As previously reported, the Company has demonstrated the ability of AAGP to protect transplanted cells in a pre-clinical experimental model of retinal degeneration.

Key Points: 
  • As previously reported, the Company has demonstrated the ability of AAGP to protect transplanted cells in a pre-clinical experimental model of retinal degeneration.
  • Two questions under study have been answered:
    Do the transplanted cells survive in the recipient and safely continue to mature into functional retinal cells?
  • At the five-month timepoint, the tests show that AAGP preserved and allowed these cells to mature without compromise.
  • The AAGP molecule in this study has overcome this considerable obstacle for stem-cell treatments that aim to replace retinal cells.

Stem Cell & Regenerative Therapy Markets to 2024 Featuring Aldagen, Caladrius Biosciences, Daiichi Sankyo Co, Gamida Cell, Novartis, and More

Retrieved on: 
Tuesday, August 20, 2019
Branches of biology, Biology, Life sciences, Regenerative biomedicine, Stem cells, Emerging technologies, Biotechnology, Developmental biology, Regenerative medicine, Stem-cell therapy

DUBLIN, Aug. 20, 2019 /PRNewswire/ -- The "Global Stem Cell and Regenerative Therapy Market: A Research Outlook" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Aug. 20, 2019 /PRNewswire/ -- The "Global Stem Cell and Regenerative Therapy Market: A Research Outlook" report has been added to ResearchAndMarkets.com's offering.
  • The current report offers a detailed analysis of the stem cell and regenerative medicines market.
  • Global stem cell and regenerative medicines market comprises of various products for novel therapeutics that are adopted across various applications.
  • These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand for stem cell and regenerative therapy among different application segments.

Global Stem Cell & Regenerative Therapy Market 2018-2024: A Research Outlook

Retrieved on: 
Thursday, August 15, 2019
Branches of biology, Biology, Life sciences, Regenerative biomedicine, Emerging technologies, Stem cells, Biotechnology, Developmental biology, Regenerative medicine, Regenerative medicine, Regenerative design, Stem-cell therapy

Dublin, Aug. 15, 2019 (GLOBE NEWSWIRE) -- The "Global Stem Cell and Regenerative Therapy Market: A Research Outlook" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • Dublin, Aug. 15, 2019 (GLOBE NEWSWIRE) -- The "Global Stem Cell and Regenerative Therapy Market: A Research Outlook" report has been added to ResearchAndMarkets.com's offering.
  • The scope of this report is broad and covers various type of product available in the stem cell and regenerative medicines market and potential application sectors across various industries.
  • The current report offers a detailed analysis of the stem cell and regenerative medicines market.
  • These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand for stem cell and regenerative therapy among different application segments.

Worldwide Stem Cell & Regenerative Therapy Markets, 2018-2019 & 2024 - Key Players are Investing in the Development of Innovative Products - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 15, 2019
Health, Stem cells, Branches of biology, Biology, Life sciences, Regenerative biomedicine, Emerging technologies, Stem cells, Biotechnology, Cloning, Regenerative medicine, Stem-cell therapy

The current report offers a detailed analysis of the stem cell and regenerative medicines market.

Key Points: 
  • The current report offers a detailed analysis of the stem cell and regenerative medicines market.
  • The report details market shares of stem cell and regenerative medicines based on products, application, and geography.
  • Global stem cell and regenerative medicines market comprises of various products for novel therapeutics that are adopted across various applications.
  • These factors are impacting the stem cell and regenerative medicines market positively and augmenting the demand for stem cell and regenerative therapy among different application segments.

Dr. Steven Victor, CEO, Medical Director of ReGen Medical, is a Co-Author of Article Published in Journal of Regenerative Medicine Vol:8 1 2019

Retrieved on: 
Friday, August 16, 2019
Branches of biology, Biology, Life sciences, Stem cells, Emerging technologies, Biotechnology, Induced stem cells, Life extension, Stem-cell therapy, Regenerative medicine, National Center for Regenerative Medicine, Clinical uses of mesenchymal stem cells

Dr. Steven Victor, General Practitioner (Regenerative Medicine) from the U.S., is an American Board-Certified Specialist in Regenerative Medicine and Regenerative Cosmetic Dermatology, with over 30 years' experience in researching, developing and providing treatment through stem cell therapy for various chronic diseases and beauty treatments.

Key Points: 
  • Dr. Steven Victor, General Practitioner (Regenerative Medicine) from the U.S., is an American Board-Certified Specialist in Regenerative Medicine and Regenerative Cosmetic Dermatology, with over 30 years' experience in researching, developing and providing treatment through stem cell therapy for various chronic diseases and beauty treatments.
  • He is the only DHA licensed physician in Regenerative Medicine in the UAE.
  • Stem Cell Therapy is a process where your own stem cells are used to repair your body.
  • Stem cells are found in the capillaries in all of your body, and they can transform into new tissue.

Global Stem Cell Market Value is Expected to Reach $28.49 Billion by 2022 - A Report by TBRC

Retrieved on: 
Tuesday, August 13, 2019
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Induced stem cells, Cell biology, Regenerative biomedicine, Stem-cell therapy, Mesoblast, Induced pluripotent stem cell, Cell therapy

The global stem cell market, valued at about $17.4 billion in 2018, is expected to grow to $28.49 billion at an annual growth rate of around 13% through 2022.

Key Points: 
  • The global stem cell market, valued at about $17.4 billion in 2018, is expected to grow to $28.49 billion at an annual growth rate of around 13% through 2022.
  • Read More On The Business Research Company's Stem Cell Market Report:
    Major players in the global stem cell therapeutics market include Anterogen Co., Ltd, Mesoblast Ltd, Osiris Therapeutics, Inc, AlloSource, and Cellular Engineering Technologies.
  • Companies in the market are focusing on development of new technologies such as the Induced Pluripotent Stem Cells (IPSC) to boost the efficiency of stem cell therapies.
  • The low acceptance rate for stem cell therapy treatments is restraining the growth of the stem cell market.

Lineage Cell Therapeutics Launches New Corporate Brand

Retrieved on: 
Monday, August 12, 2019
Research, Pharmaceutical, Optical, Oncology, Science, Clinical trials, Biotechnology, Stem cells, Health, Health, Articles, Drug discovery, Health policy, Medicinal chemistry, Therapy, Two River, Stem-cell therapy

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced the effective change of its corporate name and formal launch of its new corporate brand.

Key Points: 
  • Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, today announced the effective change of its corporate name and formal launch of its new corporate brand.
  • The new website for Lineage Cell Therapeutics will be www.lineagecell.com .
  • The Companys new identity reflects its commitment to becoming an innovative, leading cell therapy company and highlights its extensive cell therapy platform.
  • Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs.

Global Cancer Stem Cell Therapy Market Outlook to 2025 - Global Bone Marrow Transplant Market is a $15Bn Opportunity

Retrieved on: 
Tuesday, August 6, 2019
Branches of biology, Biology, Life sciences, Stem cells, Biotechnology, Cell biology, Life extension, Stem-cell therapy, Cell therapy, Cancer stem cell, Translational glycobiology, Draft:Tissue engineering

Global Bone Marrow Transplant Market Opportunity: US$ 15 Billion

Key Points: 
  • Global Bone Marrow Transplant Market Opportunity: US$ 15 Billion
    Cancer Stem Cell Therapy Clinical Pipeline: 37 Therapies
    Majority Stem Cells In Preclinical Phase: 18 Therapies
    Cancer Stem Cell Therapy Clinical Pipeline by Country: More Than 30 In USA
    Cancer incidences are escalating as a result of which demand for better therapeutics is increasing across the globe.
  • Cancer stem cell therapeutics is expected to change this scenario as they act on the very basis of the development of cancer cells.
  • Innovations in the pharmaceutical industry seem to be the main driving force for the development of cancer stem cell therapies.
  • Less number of competitors are expected to increase the profit margins and allow cancer stem cell therapy developers to occupy major market shares.

StemCyte Announces Strategic Partnership Renewal With Sharp HealthCare

Retrieved on: 
Thursday, August 8, 2019
Stem cells, Branches of biology, Biology, Life sciences, Cord blood bank, Umbilical cord, Cord blood, Sharp HealthCare, Stem-cell therapy

BALDWIN PARK, Calif., Aug. 7, 2019 /PRNewswire/ --California-based StemCyte, Inc., the pioneer in newborn stem cell therapy, is proud to announce the strategic partnership renewal with Sharp HealthCare, which includes Sharp Mary Birch Hospital for Women & Newborns.

Key Points: 
  • BALDWIN PARK, Calif., Aug. 7, 2019 /PRNewswire/ --California-based StemCyte, Inc., the pioneer in newborn stem cell therapy, is proud to announce the strategic partnership renewal with Sharp HealthCare, which includes Sharp Mary Birch Hospital for Women & Newborns.
  • StemCyte is one of the world's preeminent cord blood banks, offering both public and private cord blood banking options.
  • StemCyte is the only umbilical cord blood bank with FDA approval for Phase II clinical trial in spinal cord injury.
  • It's our goal to support Sharp HealthCare to increase overall collections, and to process and store them to the highest standards in the industry," said Charles Lu, CMO of StemCyte.